Sanna, Serena http://orcid.org/0000-0002-3768-1749
van Zuydam, Natalie R.
Mahajan, Anubha http://orcid.org/0000-0001-5585-3420
Kurilshikov, Alexander http://orcid.org/0000-0003-2541-5627
Vich Vila, Arnau http://orcid.org/0000-0003-4691-5583
Võsa, Urmo
Mujagic, Zlatan
Masclee, Ad A. M.
Jonkers, Daisy M. A. E.
Oosting, Marije
Joosten, Leo A. B. http://orcid.org/0000-0001-6166-9830
Netea, Mihai G. http://orcid.org/0000-0003-2421-6052
Franke, Lude http://orcid.org/0000-0002-5159-8802
Zhernakova, Alexandra
Fu, Jingyuan http://orcid.org/0000-0001-5578-1236
Wijmenga, Cisca http://orcid.org/0000-0002-5635-1614
McCarthy, Mark I. http://orcid.org/0000-0002-4393-0510
Article History
Received: 13 June 2018
Accepted: 10 January 2019
First Online: 18 February 2019
Competing interests
: M.I.M. serves on advisory panels for Pfizer, NovoNordisk and Zoe Global; has received honoraria from Pfizer, NovoNordisk and Eli Lilly; has stock options in Zoe Global; and has received research funding from Abbvie, Astra Zeneca, Boehringer Ingelheim, Eli Lilly, Janssen, Merck, NovoNordisk, Pfizer, Roche, Sanofi Aventis, Servier and Takeda. All other authors declare no competing financial interests.